Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.

Magdalena KlanovaMikkel Z OestergaardMarek TrněnýWolfgang HiddemannRobert MarcusLaurie H SehnUmberto VitoloAlexandra BazeosValentin GoedeHarald ZeunerAndrea KnappDeniz SahinNathalie SpielewoyChristopher R BolenAndres CardonaChristiane NeumannJeffrey M VenstromTina NielsenGünter Fingerle-Rowson

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

These findings indicate that the number of NK cells in peripheral blood may affect the outcome of patients with B-cell non-Hodgkin lymphoma receiving anti-CD20-based immunochemotherapy.

Keyphrases

diffuse large b cell lymphoma
nk cells
peripheral blood
epstein barr virus
single cell
cell therapy
bone marrow